CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 71 filers reported holding CLEARSIDE BIOMEDICAL INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4 | +100.0% | 4,849 | +123.5% | 0.00% | – |
| Q2 2023 | $2 | -100.0% | 2,170 | -91.1% | 0.00% | – |
| Q3 2022 | $27,000 | -28.9% | 24,458 | -7.6% | 0.00% | – |
| Q2 2022 | $38,000 | +111.1% | 26,461 | +222.8% | 0.00% | – |
| Q1 2022 | $18,000 | +12.5% | 8,197 | +36.2% | 0.00% | – |
| Q4 2021 | $16,000 | – | 6,017 | +30.8% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 4,600 | -67.2% | 0.00% | – |
| Q2 2020 | $26,000 | +4.0% | 14,004 | -7.3% | 0.00% | – |
| Q1 2020 | $25,000 | -88.6% | 15,107 | -80.1% | 0.00% | – |
| Q4 2019 | $220,000 | – | 75,870 | +16685.4% | 0.00% | – |
| Q3 2019 | $0 | – | 452 | -2.6% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 464 | -87.3% | 0.00% | – |
| Q4 2018 | $3,000 | -90.0% | 3,641 | -27.6% | 0.00% | – |
| Q3 2018 | $30,000 | -90.3% | 5,027 | -82.6% | 0.00% | -100.0% |
| Q2 2018 | $308,000 | – | 28,861 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 3,917,622 | $7,365,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 54,092 | $102,000 | 0.06% |
| Carmignac Gestion | 1,937,608 | $3,643,000 | 0.05% |
| OXFORD FINANCIAL GROUP, LTD. LLC | 91,824 | $173,000 | 0.03% |
| SIGNATUREFD, LLC | 121,351 | $228,000 | 0.01% |
| Tekla Capital Management LLC | 165,330 | $311,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 184,000 | $346,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 567,903 | $1,068,000 | 0.01% |
| Integrated Advisors Network LLC | 15,700 | $30,000 | 0.00% |
| WEDBUSH SECURITIES INC | 22,900 | $43,000 | 0.00% |